PMID- 22949667 OWN - NLM STAT- MEDLINE DCOM- 20121210 LR - 20211021 IS - 1091-6490 (Electronic) IS - 0027-8424 (Print) IS - 0027-8424 (Linking) VI - 109 IP - 38 DP - 2012 Sep 18 TI - Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron development. PG - 15491-6 AB - Neurotrophic factors, such as brain-derived neurotrophic factor (BDNF), are associated with the physiology of the striatum and the loss of its normal functioning under pathological conditions. The role of BDNF and its downstream signaling in regulating the development of the striatum has not been fully investigated, however. Here we report that ablation of Bdnf in both the cortex and substantia nigra depletes BDNF in the striatum, and leads to impaired striatal development, severe motor deficits, and postnatal lethality. Furthermore, striatal-specific ablation of TrkB, the gene encoding the high-affinity receptor for BDNF, is sufficient to elicit an array of striatal developmental abnormalities, including decreased anatomical volume, smaller neuronal nucleus size, loss of dendritic spines, reduced enkephalin expression, diminished nigral dopaminergic projections, and severe deficits in striatal dopamine signaling through DARPP32. In addition, TrkB ablation in striatal neurons elicits a non-cell-autonomous reduction of tyrosine hydroxylase protein level in the axonal projections of substantia nigral dopaminergic neurons. Thus, our results establish an essential function for TrkB in regulating the development of striatal neurons. FAU - Li, Yun AU - Li Y AD - Department of Developmental Biology and Kent Waldrep Center for Basic Research on Nerve Growth and Regeneration, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. FAU - Yui, Daishi AU - Yui D FAU - Luikart, Bryan W AU - Luikart BW FAU - McKay, Renee M AU - McKay RM FAU - Li, Yanjiao AU - Li Y FAU - Rubenstein, John L AU - Rubenstein JL FAU - Parada, Luis F AU - Parada LF LA - eng GR - P50 MH066172/MH/NIMH NIH HHS/United States GR - R37 NS033199/NS/NINDS NIH HHS/United States GR - 7P50MH066172-07/MH/NIMH NIH HHS/United States GR - R37NS033199/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120904 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Brain-Derived Neurotrophic Factor) RN - EC 1.14.16.2 (Tyrosine 3-Monooxygenase) RN - EC 2.7.10.1 (Receptor, trkB) SB - IM MH - Animals MH - Axons/metabolism MH - Brain-Derived Neurotrophic Factor/*metabolism MH - Corpus Striatum/*metabolism MH - *Gene Expression Regulation MH - Mice MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - Models, Biological MH - Neurons/*metabolism MH - Receptor, trkB/*metabolism MH - *Signal Transduction MH - Substantia Nigra/metabolism MH - Tyrosine 3-Monooxygenase/metabolism PMC - PMC3458400 COIS- The authors declare no conflict of interest. EDAT- 2012/09/06 06:00 MHDA- 2012/12/12 06:00 PMCR- 2013/03/18 CRDT- 2012/09/06 06:00 PHST- 2012/09/06 06:00 [entrez] PHST- 2012/09/06 06:00 [pubmed] PHST- 2012/12/12 06:00 [medline] PHST- 2013/03/18 00:00 [pmc-release] AID - 1212899109 [pii] AID - 201212899 [pii] AID - 10.1073/pnas.1212899109 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15491-6. doi: 10.1073/pnas.1212899109. Epub 2012 Sep 4.